Skip to main content
. 2019 Dec 29;4(2):298–308. doi: 10.1002/rth2.12295

Figure 2.

Figure 2

TGA peak height of blood samples from patients with hemophilia A under the following conditions: (A) PPP, (B) PPP+CTI, (C) PRP, and (D) PRP+CTI. CTI, corn trypsin inhibitor; PPP; platelet‐poor plasma, PRP; platelet‐rich plasma, TGA, thrombin generation assay